IMMUNECYTE

ImmuneCyte is a clinical stage cell therapy company focused on delivering critical impacts on cancer, vascular, orthopedic, and aging-related diseases... ImmuneCyte Inc. is a global, clinical-stage biopharmaceutical company engaged in the research and development of innovative cell and gene therapeutics, including chimeric antigen receptor (CAR)-T cell, CAR-NK cell, and mononuclear cell therapies, for the treatment of cancer, vascular, orthopedic and aging-related diseases. We are a privately held company with headquarter in Irvine, California and access to 30,000 sq. ft. of GMP-qualified laboratory and office facilities in Tianjin, China. The location of our operations provides us with many potential strategic advantages, including proximity to world's largest pharmaceutical market and access to largest number of patients... We build our immuno-oncology pipeline based on our proprietary CARTXpress™ platform, licensed from one of our parent companies, ThermoGenesis Holdings Inc. The..

Also known as: ImmuneCyte, Inc.

Primary location: Irvine United States